Chamara Visanka Senaratna

Dr. Chamara Visanka Senaratna


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
CSChamara Visanka Senaratna
Chamara Visanka Senaratna
JPJennifer L. Perret
Jennifer L. Perret
CLCaroline Lodge
Caroline Lodge
Adrian LoweAdrian Lowe
Adrian Lowe
BCBrittany E. Campbell
Brittany E. Campbell
Shyamali DharmageShyamali Dharmage
Shyamali Dharmage

1 December 2017 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
CSChamara Visanka Senaratna
Chamara Visanka Senaratna
JPJennifer Perret
Jennifer Perret
MMMelanie C. Matheson
Melanie C. Matheson
CLCaroline Lodge
Caroline Lodge
Adrian LoweAdrian Lowe
Adrian Lowe
Shyamali DharmageShyamali Dharmage
Shyamali Dharmage

1 April 2017 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
SSShajedur R. Shawon
Shajedur R. Shawon
JPJennifer L. Perret
Jennifer L. Perret
CSChamara Visanka Senaratna
Chamara Visanka Senaratna
CLCaroline Lodge
Caroline Lodge
GHGarun S. Hamilton
Garun S. Hamilton
Shyamali DharmageShyamali Dharmage
Shyamali Dharmage

1 December 2018 in Sleep Medicine Reviews
Verified
Journal Article
Closed access
AWAi-Ming Wong
Ai-Ming Wong
HBHayley N. Barnes
Hayley N. Barnes
SJSimon A Joosten
Simon A Joosten
SLShane Landry
Shane Landry
EDEli Dabscheck
Eli Dabscheck
GHGarun S. Hamilton
Garun S. Hamilton

31 October 2016 in BMC Public Health
Verified
Journal Article
Open access
PDF file
CSChamara Visanka Senaratna
Chamara Visanka Senaratna
DEDallas English
Dallas English
DCDianne Currier
Dianne Currier
JPJennifer L. Perret
Jennifer L. Perret
Adrian LoweAdrian Lowe
Adrian Lowe
Shyamali DharmageShyamali Dharmage
Shyamali Dharmage
Obstructive sleep apnoea is a common disorder with under-rated clinical impact, which is increasingly being recognised as having a major bearing on global disease burden. Men are especially vulnerable and become a priority group for preventative interventions. However, there is limited information on prevalence of the condition in Australia, its co-morbidities, and potential risk factors. We used data from 13,423 adult men included in the baseline wave of Ten to Men, an Australian national study of the health of males, assembled using stratified cluster sampling with oversampling from rural and regional areas. Those aged 18–55 years self-completed a paper-based questionnaire that included a question regarding health professional-diagnosed sleep apnoea, physical and mental health status, and health-related behaviours. Sampling weights were used to account for the sampling design when reporting the prevalence estimates. Odds ratios were used to describe the association between health professional-diagnosed sleep apnoea and potential correlates while adjusting for age, country of birth, and body-mass index (BMI). Prevalence of self-reported health professional-diagnosed sleep apnoea increased from 2.2 % in age 18–25 years to 7.8 % in the age 45–55 years. Compared with those without sleep apnoea, those with sleep apnoea had significantly poorer physical, mental, and self-rated health as well as lower subjective wellbeing and poorer concentration/remembering (p < 0.001 for all). Sleep apnoea was significantly associated with older age (p < 0.001), unemployment (p < 0.001), asthma (p = 0.011), chronic obstructive pulmonary disease/chronic bronchitis (p = 0.002), diabetes (p < 0.001), hypercholesterolemia (p < 0.001), hypertension (p < 0.001), heart attack (p < 0.001), heart failure (p < 0.001), angina (p < 0.001), depression (p < 0.001), post-traumatic stress disorder (p < 0.001), other anxiety disorders (p < 0.001), schizophrenia (p = 0.002), overweight/obesity (p < 0.001), insufficient physical activity (p = 0.006), smoking (p = 0.005), and high alcohol consumption (p < 0.001). Health professional-diagnosed sleep apnoea is relatively common, particularly in older males. Associations between sleep apnoea and cardiovascular, metabolic, respiratory, and psychiatric disorders have important clinical and public health implications. As men are especially vulnerable to sleep apnoea as well as some of its chronic co-morbidities, they are potentially a priority group for health interventions. Modifiable lifestyle related factors such as smoking, alcohol consumption, level of physical activity and BMI are possible key foci for interventions.

3 May 2019 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
CSChamara Visanka Senaratna
Chamara Visanka Senaratna
JPJennifer L Perret
Jennifer L Perret
ALAdrian Lowe
Adrian Lowe
Gayan BowatteGayan Bowatte
Gayan Bowatte
MAMichael J Abramson
Michael J Abramson
Shyamali DharmageShyamali Dharmage
Shyamali Dharmage
Objective To examine the utility of apnoea screening questionnaires, alone and in combination with the Epworth sleepiness scale (ESS), for detecting obstructive sleep apnoea (OSA) in primary care. Design, setting Prospective validation study in an Australian general population cohort. Participants 424 of 772 randomly invited Tasmanian Longitudinal Health Study, 6th decade follow‐up participants with OSA symptoms (mean age, 52.9 years; SD, 0.9 year) who completed OSA screening questionnaires and underwent type 4 sleep studies. Main outcome measures Clinically relevant OSA, defined as moderate to severe OSA (15 or more oxygen desaturation events/hour), or mild OSA (5–14 events/hour) and excessive daytime sleepiness (ESS ≥ 8); diagnostic test properties of the Berlin (BQ), STOP‐Bang and OSA‐50 questionnaires, alone or combined with an ESS ≥ 8. Results STOP‐Bang and OSA‐50 correctly identified most participants with clinically relevant OSA (sensitivity, 81% and 86% respectively), but with poor specificity (36% and 21% respectively); the specificity (59%) and sensitivity of the BQ (65%) were both low. When combined with the criterion ESS ≥ 8, the specificity of each questionnaire was high (94–96%), but sensitivity was low (36–51%). Sensitivity and specificity could be adjusted according to specific needs by varying the STOP‐Bang cut‐off score when combined with the ESS ≥ 8 criterion. Conclusions For people likely to trigger OSA assessment in primary care, the STOP‐Bang, BQ, and OSA‐50 questionnaires, combined with the ESS, can be used to rule in, but not to rule out clinically relevant OSA. Combined use of the STOP‐Bang with different cut‐off scores and the ESS facilitates a flexible balance between sensitivity and specificity.